HPR71 Evaluating the ICER Special Report in the Context of Medicare Drug Price Negotiations: Implications for Manufacturer Pricing and Evidence Strategies
Abstract
Authors
Breyanne Bannister Alissa Shaul Jeff Lee Jonathan Kowalski